Metabolism
Metabolism inhibitors are compounds that interfere with metabolic pathways, altering the production and utilization of energy within cells. These inhibitors are used to study the regulation of metabolism, the role of metabolic pathways in diseases like cancer and diabetes, and to develop new therapeutic strategies. Metabolism inhibitors can target various enzymes and processes involved in glycolysis, fatty acid oxidation, and other metabolic functions. At CymitQuimica, we offer a wide range of high-quality metabolism inhibitors to support your research in biochemistry, metabolic disorders, and drug development.
Subcategories of "Metabolism"
- AhR(41 products)
- Aminopeptidase(75 products)
- CETP(20 products)
- Carbonic Anhydrase(191 products)
- Casein Kinase(137 products)
- DHFR(34 products)
- Decarboxylase(4 products)
- Dehydrogenase(300 products)
- FAAH(65 products)
- FXR(61 products)
- Factor Xa(85 products)
- Fatty Acid Synthase(38 products)
- Ferroptosis(225 products)
- GR(3 products)
- GSNOR(4 products)
- Glucokinase(56 products)
- HIF/HIF Prolyl-Hydroxylase(146 products)
- HMG-CoA Reductase(33 products)
- Hydroxylase(35 products)
- IDO(84 products)
- LDL(8 products)
- Lipase(105 products)
- Lipid(61 products)
- Lipoxygenase(136 products)
- MAO(87 products)
- MPO(2 products)
- NAMPT(40 products)
- P450(6 products)
- PAI-1(25 products)
- PDE(166 products)
- PED(1 products)
- PKM(16 products)
- PPAR(169 products)
- Phospholipase(82 products)
- ROR(46 products)
- Retinoid Receptor(28 products)
- SGK(11 products)
- Thioredoxin(12 products)
- Transferase(29 products)
- Transporter(46 products)
- UGT(4 products)
- Xanthine Oxidase (XO) Inhibitors(9 products)
Show 34 more subcategories
Found 9214 products of "Metabolism"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
PPARγ-IN-2
CAS:<p>"PPARγ-IN-2 (Compound 5a), a PPARγ inhibitor, exhibits an EC50 of 0.106 μM in inhibiting TG accumulation in 3T3-L1 preadipocytes.</p>Formula:C19H21N5OPurity:98%Color and Shape:SolidMolecular weight:335.4Lp-PLA2-IN-12
CAS:<p>Lp-PLA2-IN-12 (compound 19), an Lp-PLA2 inhibitor, is utilized in researching neurodegenerative diseases including Alzheimer's disease (AD), glaucoma, age-</p>Formula:C24H23F2N5O3Purity:98%Color and Shape:SolidMolecular weight:467.47GKA50
CAS:GKA50 stimulates insulin release from mouse islets of Langerhans and MIN6 cells. GKA50 shows significant glucose lowering in high fat fed female rats. GKA50 is a potent glucokinase activator (EC50=33 nM at 5 mM glucose).Formula:C26H28N2O6Purity:98%Color and Shape:SolidMolecular weight:464.51MDK-2959
CAS:MDK-2959 is a potent inhibitor of protein tyrosine phosphatase sigma (PTPsigma).Formula:C15H11N3O4Purity:98%Color and Shape:SolidMolecular weight:297.27Lp-PLA2-IN-15
CAS:<p>Lp-PLA2-IN-15 (example 2) is an inhibitor of lipoprotein-associated phospholipase A2 (Lp-PLA2) with potential application in Alzheimer's disease research [1].</p>Formula:C22H17F5N4O3Purity:98%Color and Shape:SolidMolecular weight:480.39Mavodelpar free base
CAS:<p>Mavodelpar free acid (REN001 free acid) is an selective agonist of PPARδ.</p>Formula:C31H30FNO5Purity:98%Color and Shape:SolidMolecular weight:515.57Desmethyl ferroquine
CAS:Desmethyl ferroquine is the active and major metabolite of Ferroquine.Desmethyl ferroquine shows significant activity against Chloroquine-susceptible and resistant P. falciparum strains. Ferroquine is an antimalarial.Formula:C22H22ClFeN3Purity:98%Color and Shape:SolidMolecular weight:419.731-Methyladenine
CAS:1-Methyladenine is a DNA alkylation product that undergoes damage reversal through oxidative demethylation for repair purposes.Formula:C6H7N5Purity:98%Color and Shape:SolidMolecular weight:149.15URAT1&XO inhibitor 1
CAS:<p>URAT1&XO Inhibitor 1 (compound 29) serves as a dual inhibitor with IC50 values of approximately 10 μM for URAT1 and 1.01 μM for Xanthine Oxidase.</p>Formula:C20H13N5O3SPurity:98%Color and Shape:SolidMolecular weight:403.41I5B2
CAS:<p>I5B2 is a novel phosphorus-containing angiotensin I converting enzyme inhibitor. Angiotensin I converting enzyme is produced by Actinomadura sp.</p>Formula:C23H32N3O7PPurity:98%Color and Shape:SolidMolecular weight:493.49CJ-13,610
CAS:CJ-13,610 is an orally active and nonredox-type inhibitor of 5-lipoxygenase (5-LOX). CJ-13,610 inhibits the biosynthesis of leukotriene B4 and regulates the expression of IL-6 mRNA in macrophages.Formula:C22H23N3O2SPurity:99.64%Color and Shape:SolidMolecular weight:393.5IDO1-IN-22
CAS:<p>IDO1-IN-22 (Compound 3) is an inhibitor of IDO1, demonstrating potent activity with biochemical hIDO1 IC50 of 67.4 nM and HeLa hIDO1 IC50 of 17.6 nM.</p>Formula:C12H12BrFN6O3Purity:98%Color and Shape:SolidMolecular weight:387.16SH1573
CAS:<p>SH1573 is an orally active inhibitor of mutant isocitrate dehydrogenase 2 (mIDH2). It selectively targets the mIDH2 R140Q protein with a potent inhibitory effect (IC50=4.78 nmol/L), significantly reducing the production of the oncogenic metabolite 2-hydroxyglutarate (2-HG) in animal models, cell lines, serum, and tumors. SH1573 is utilized in the study of acute myeloid leukemia (AML).</p>Formula:C21H18F9N7O4SColor and Shape:SolidMolecular weight:635.46Ref: TM-T200209
Discontinued productCC15009
CAS:<p>CC15009 is a potent inhibitor of xanthine oxidoreductase (XOR), demonstrating an IC50 value of 0.237 nM. It effectively inhibits the oxidative subtype of XOR, thereby reducing the generation of the byproduct ROS and exhibiting antioxidant activity. CC15009 has shown a favorable dose-dependent uric acid-lowering effect in two different XOR substrate-induced hyperuricemia mouse models.</p>Formula:C20H21Cl2N5O2Color and Shape:SolidMolecular weight:434.32Ref: TM-T200445
Discontinued product
